Ventyx Biosciences, Inc.
Total Trades
124
Buys
2
Sells
86
Largest Trade
N/A
Insiders
9
Institutional Funds
96
Inst. Value
$1M+
Activist Filings
50
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Mohan Raju | CEO AND PRESIDENT | EXERCISE | N/A | 117K | — | Dec 19, 2025 |
| Mohan Raju | CEO AND PRESIDENT | SELL | $100K–$500K | 47K | $7.72 | Dec 19, 2025 |
| Nuss John | CHIEF SCIENTIFIC O… | EXERCISE | N/A | 35K | — | Dec 19, 2025 |
| Nuss John | CHIEF SCIENTIFIC O… | SELL | $50K–$100K | 13K | $7.72 | Dec 19, 2025 |
| Nuss John | CHIEF SCIENTIFIC O… | SELL | $1K–$15K | 2K | $1.07 | Apr 3, 2025 |
| Nuss John | CHIEF SCIENTIFIC O… | SELL | $15K–$50K | 21K | $2.36 | Dec 30, 2024 |
| Gujrathi Sheila | Director | BUY | $100K–$500K | 130K | $2.31 | Dec 27, 2024 |
| Mohan Raju | CEO AND PRESIDENT | BUY | $500K+ | 500K | $1.92 | Nov 26, 2024 |
| Krueger Christopher W | CHIEF BUSINESS OFF… | SELL | $1K–$15K | 2K | $5.40 | Apr 3, 2024 |
| Nuss John | CHIEF SCIENTIFIC O… | SELL | $1K–$15K | 2K | $5.40 | Apr 3, 2024 |
| Mohan Raju | CEO AND PRESIDENT | SELL | $15K–$50K | 4K | $5.40 | Apr 3, 2024 |
| Auster Martin | CHIEF FINANCIAL OF… | SELL | $1K–$15K | 1K | $5.40 | Apr 3, 2024 |
| Nuss John | Chief Scientific O… | SELL | $15K–$50K | 18K | $2.12 | Dec 22, 2023 |
| Krueger Christopher W | Chief Business Off… | SELL | $1K–$15K | 5K | $2.12 | Dec 22, 2023 |
| Mohan Raju | CEO and President | SELL | $100K–$500K | 59K | $2.12 | Dec 22, 2023 |
| NSV Partners III LP | 10% Owner | SELL | $1M+ | 49K | $30.03 | Oct 11, 2023 |
| Subramaniam Somu | Director | SELL | $1M+ | 49K | $30.03 | Oct 11, 2023 |
| Mohan Raju | CEO | EXERCISE | $100K–$500K | 30K | $8.04 | Oct 6, 2023 |
| Mohan Raju | CEO | SELL | $500K+ | 30K | $29.11 | Oct 6, 2023 |
| Krueger Christopher W | Chief Business Off… | SELL | $100K–$500K | 15K | $29.98 | Oct 4, 2023 |
| Krueger Christopher W | Chief Business Off… | EXERCISE | $100K–$500K | 15K | $8.04 | Oct 4, 2023 |
| Nuss John | Chief Scientific O… | EXERCISE | $15K–$50K | 10K | $3.35 | Oct 4, 2023 |
| Nuss John | Chief Scientific O… | SELL | $100K–$500K | 10K | $29.99 | Oct 4, 2023 |
| Subramaniam Somu | Director | SELL | $1M+ | 57K | $37.81 | Sep 20, 2023 |
| NSV Partners III LP | 10% Owner | SELL | $1M+ | 57K | $37.81 | Sep 20, 2023 |
| Auster Martin | CFO | SELL | $500K+ | 26K | $32.61 | Sep 7, 2023 |
| Krueger Christopher W | Chief Business Off… | SELL | $100K–$500K | 15K | $32.61 | Sep 7, 2023 |
| Krueger Christopher W | Chief Business Off… | EXERCISE | $100K–$500K | 15K | $8.04 | Sep 7, 2023 |
| Mohan Raju | CEO | SELL | $500K+ | 30K | $32.61 | Sep 7, 2023 |
| Mohan Raju | CEO | EXERCISE | $100K–$500K | 30K | $8.04 | Sep 7, 2023 |
| Nuss John | Chief Scientific O… | SELL | $100K–$500K | 10K | $32.60 | Sep 7, 2023 |
| Nuss John | Chief Scientific O… | EXERCISE | $1K–$15K | 10K | $0.20 | Sep 7, 2023 |
| Sandborn William J. | See Remarks | SELL | $100K–$500K | 12K | $33.64 | Sep 1, 2023 |
| Sandborn William J. | See Remarks | EXERCISE | $100K–$500K | 12K | $14.85 | Sep 1, 2023 |
| Sandborn William J. | See Remarks | SELL | $100K–$500K | 3K | $32.86 | Aug 8, 2023 |
| Mohan Raju | CEO | EXERCISE | $100K–$500K | 30K | $8.04 | Aug 8, 2023 |
| Mohan Raju | CEO | SELL | $1M+ | 30K | $33.52 | Aug 8, 2023 |
| Nuss John | Chief Scientific O… | EXERCISE | $1K–$15K | 10K | $0.20 | Aug 4, 2023 |
| Nuss John | Chief Scientific O… | SELL | $100K–$500K | 10K | $35.60 | Aug 4, 2023 |
| Krueger Christopher W | Chief Business Off… | EXERCISE | $100K–$500K | 15K | $8.04 | Aug 4, 2023 |
| Krueger Christopher W | Chief Business Off… | SELL | $500K+ | 15K | $35.59 | Aug 4, 2023 |
| Subramaniam Somu | Director | SELL | $100K–$500K | 11K | $37.58 | Aug 1, 2023 |
| NSV Partners III LP | 10% Owner | SELL | $100K–$500K | 11K | $37.58 | Aug 1, 2023 |
| Sandborn William J. | See Remarks | EXERCISE | $100K–$500K | 12K | $14.85 | Aug 1, 2023 |
| Sandborn William J. | See Remarks | SELL | $100K–$500K | 12K | $37.16 | Aug 1, 2023 |
| Auster Martin | CFO | SELL | $500K+ | 28K | $35.54 | Jul 26, 2023 |
| Auster Martin | CFO | EXERCISE | $50K–$100K | 28K | $3.45 | Jul 26, 2023 |
| NSV Partners III LP | 10% Owner | SELL | $1M+ | 32K | $37.55 | Jul 14, 2023 |
| Subramaniam Somu | Director | SELL | $1M+ | 32K | $37.55 | Jul 14, 2023 |
| Subramaniam Somu | Director | SELL | $1M+ | 100K | $35.23 | Jul 12, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 96 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 6.5M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 2.8M | $1M+ | SH |
| MORGAN STANLEY | 2.2M | $1M+ | SH |
| BRAIDWELL LP | 1.9M | $1M+ | SH |
| MPM BioImpact LLC | 1.6M | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 1.2M | $1M+ | SH |
| Point72 Asset Management, L.P. | 1.1M | $1M+ | SH |
| Ikarian Capital, LLC | 959K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 774K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 736K | $1M+ | SH |
| Artia Global Partners LP | 696K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 654K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 591K | $1M+ | SH |
| TUDOR INVESTMENT CORP ET AL | 584K | $1M+ | SH |
| STATE STREET CORP | 549K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 538K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 452K | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 430K | $1M+ | SH |
| Squadron Capital Management LLC | 410K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 383K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Mar 5, 2026
0.0%
0 shares
SC 13G · Feb 19, 2026
6.2%
4.4M shares
SC 13G/A · Feb 6, 2026
0.3%
237K shares
SC 13G · Feb 5, 2026
6.0%
4.3M shares
SC 13G/A · Jan 30, 2026
9.0%
6.5M shares
SC 13D/A · Jan 10, 2026
5.8%
4.1M shares
SC 13D/A · Jan 10, 2026
6.0%
4.4M shares
SC 13D · Nov 27, 2025
6.0%
4.4M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 14, 2025
4.5%
3.2M shares
SC 13G · Oct 31, 2025
5.3%
3.8M shares
Point72 Asset Management, L.P.
SC 13G/A · Aug 14, 2025
8.3%
5.9M shares
SC 13G · May 30, 2025
5.7%
4.1M shares
SC 13G/A · May 15, 2025
2.0%
1.4M shares
SC 13G/A · May 15, 2025
1.4%
1.0M shares
SC 13G/A · Apr 8, 2025
3.6%
2.6M shares
SC 13D/A · Apr 2, 2025
4.5%
3.2M shares
SC 13D/A · Mar 12, 2025
4.4%
3.1M shares
SC 13G · Feb 14, 2025
6.5%
4.6M shares
SC 13G/A · Feb 13, 2025
0.8%
535K shares
SC 13G · Feb 10, 2025
5.7%
4.0M shares
Point72 Asset Management, L.P.
SC 13G · Jan 29, 2025
6.2%
4.4M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
0.1%
47K shares
Cormorant Asset Management, LP
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G/A · Nov 14, 2024
9.5%
6.7M shares
SC 13G/A · Nov 12, 2024
4.9%
3.5M shares
SC 13G/A · Nov 4, 2024
4.9%
3.5M shares
SC 13D/A · Jun 26, 2024
6.9%
4.9M shares
SC 13G · Apr 4, 2024
5.0%
3.5M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G · Mar 21, 2024
5.2%
3.7M shares
SC 13D/A · Mar 13, 2024
7.1%
5.0M shares
SC 13D/A · Mar 8, 2024
8.5%
5.0M shares
Point72 Asset Management, L.P.
SC 13G · Feb 23, 2024
5.0%
3.0M shares
SC 13G/A · Feb 14, 2024
5.9%
6 shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
6.3%
3.7M shares
SC 13G · Jan 29, 2024
5.2%
3.1M shares
SC 13G · Jan 29, 2024
6.5%
3.8M shares
SC 13G/A · Dec 11, 2023
0.5%
323K shares
SC 13D/A · Jul 19, 2023
8.6%
5.0M shares
SC 13D/A · Jul 11, 2023
9.1%
5.3M shares
SC 13G · Apr 10, 2023
13.1%
7.6M shares
SC 13D/A · Apr 7, 2023
9.6%
5.6M shares
SC 13D/A · Mar 22, 2023
9.8%
5.6M shares
SC 13D/A · Mar 2, 2023
9.8%
5.6M shares
SC 13G/A · Feb 14, 2023
6.7%
6 shares
venBio Global Strategic Fund III, L.P.
SC 13D/A · Jan 30, 2023
4.8%
2.7M shares
SC 13D/A · Dec 30, 2022
9.8%
5.6M shares
SC 13D/A · Dec 16, 2022
9.8%
5.6M shares
venBio Global Strategic Fund III, L.P.
SC 13D/A · Dec 15, 2022
6.1%
3.5M shares
SC 13D/A · Nov 9, 2022
4.0%
2.3M shares
SC 13D/A · Sep 21, 2022
10.4%
5.9M shares